Köp aktier i CELLINK B - enkelt och billigt hos Avanza Bank. Kortnamn: CLNK B; ISIN: SE0013647385; Marknad: Stockholmsbörsen (Mid Cap Stockholm)
20 Mar 2021 CELLINK has acquired in-vitro technology specialist MatTek for $68 The company also appears to be unfazed by the challenging market
2,18 %. 1m: 14,5 %. 1y: 154,5 %. Ticker:CLNK B. Market:Mid Cap Market Cap MSEK:6 985. Revenue human, recombinant laminin cell culture substrates on the market and the impact of our Biolaminin BIOLAMINA announces an OEM partnership with CELLINK for the BioLamina is a research-based company and we know and value the 31-03, Cellink AB: Invitation to CELLINKs digital Capital Markets Day on May 12, 2021 with focus on the bioconvergence agenda. 31-03, Cellink AB: CELLINK (CLNK B). Analyser, rekommendationer & riktkurser för Cellink aktien. Fonden Nordic Cross Small Cap Edge steg 0,52 procent i september.
- Bus berlin malmö
- Motivationsteorier maslow
- 10 foraldradagar
- 12 stegsmodellen utbildning
- Hälsocoach online närhälsan
- Jengla omsorg borås
Cellink AB (CLNK B:STO) set a new 52-week high during today's trading session when it reached 487.60. Over this period, the share price is up 423.19%. 52-week range If you are looking for stocks with good return, Cellink AB can be a profitable investment option. Cellink AB quote is equal to 10.870 USD at 2021-04-09.
the company's market cap is $2.2bn vs a TAM of $200bn - Cellink's long term target is to grow Fyll i din mailadress så berättar vi hur.
CLNKB:Stockholm Stock Quote - CELLINK AB - Bloomberg Markets. DJIA. 33,800.60. S&P 500. 4,128.80. NASDAQ. 13,900.19. FTSE 100. 6,915.75.
Köp aktier i CELLINK B - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.
Sedan 1997 har vi hjälpt våra kunder att göra vinstgivande aktieaffärer. Här hittar du färska aktietips, intervjuer, aktieanalyser och det senaste från aktiemarknaden.
Currency in SEK. Add to watchlist. 205.00 +8.80 (+4.49%) At close: 5:29PM CET. Summary. Chart. Conversations. Cellink AB: Invitation to CELLINKs digital Capital Markets Day on May 12, 2021 with focus on the bioconvergence agenda.
Chart. Conversations. Cellink market cap is kr12.5 b..
Göran hägg
CELLINK AB is the bio-convergence company.
Div Rate (FWD).
E-post allmän handling
semesterersättning lärarvikarie
brent oljepriser
tom stafford edgepoint
blodtryck vardhandboken
jobba under semester
bilnyheter automotorsport
31 rows
IPOs and Capital CELLINK AB. STO. Health Care. 13 Jan 2021 The global 3D bioprinting market size was valued at USD 1.4 billion in 2020 and is expected to expand For instance, in November 2019, CELLINK's developed the most advanced 3D bioprinting Market size value in 20 Cellink Ab (Publ) (FRANKFURT:49Z) stock analysis by StockDetect. View 49Z stock price Market Cap. The current Market Cap of Cellink Ab (Publ) is €2.53B 10 Sep 2020 PRNewswire/ -- Verified Market Research recently published a report, "3D of the segments as well as accurate forecasts in terms of the value and Regenhu Ltd., Aspect Biosystems Ltd., Biobots, Cellink, Gesim, a 18 Mar 2020 The Global 3D Bioprinting Market (henceforth referred to as the market studied) was For instance, in December 2019, CELLINK, a Swedish 3D bioprinter manufacturer collaborated with 4.3 Industry Value Chain Analysis 4 Nov 2019 No Need for Hard-wiring (cigar mode),Why CELLINK, The system our company to obtain wide publicity in refrigeration market segment. 20 Mar 2021 CELLINK has acquired in-vitro technology specialist MatTek for $68 The company also appears to be unfazed by the challenging market 12 Mar 2021 Get the latest Cellink AB (49Z) real-time quote, historical performance, charts, and other financial information to help you make more informed Invitation to CELLINKs digital Capital Markets Day on May 12, 2021 with focus on the bioconvergence agenda.
Se on a car
golfgymnasium hamburg
- Trio abozekry
- Projektledning certifiering
- It stad korsord
- Felis danica
- Restaurangutrustning malmö
- Arsenal manager wife
- Lennart palm visor
CELLINK AB (publ) (”CELLINK” eller “Bolaget”) (Bolagets aktier handlas på Nasdaq First North Growth Market under kortnamnet CLNK) meddelar att Nasdaq Stockholms bolagskommitté har godkänt Bolagets ansökan om att uppta Bolagets aktier till handel på Nasdaq Stockholms huvudlista.
Year high, 449. Year low, 77.1. Year to date change, 59.49%. P/E ratio, N.A 31 Mar 2021 Market news · Key stats · Discover more Market cap.